[1] 中华医学会儿科学分会消化学组,中华医学会儿科学分会临床营养学组.儿童炎症性肠病诊断和治疗专家共识[J].中华儿科杂志,2019,57(7):501-507.
[2] GARG M,ROYCR S G,TIKELLIS C,et al.Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD:a novel therapeutic target?[J].Gut,2020,69(5):841-851.
[3] 袁柏思,金鑫鑫,路又可,等.克罗恩病简化内镜评分(SES-CD)与临床和实验室指标相关性的研究[J].胃肠病学,2017,22(3):6.
[4] ZHANG Y Z,LI Y Y.Inflammatory bowel disease:pathogenesis[J].World J gastroenterol,2014,20(1):91-99.
[5] BRATLIE S O,EDEBO A,CASSELBRANT A,et al.The renin-angiotensin system in Barrett's esophagus[J].Scand J Gastroenterol,2016,51(9):1037-1042.
[6] HRENAK J,PAULIS L,SIMKO F.Angiotensin A/Alamandine/MrgD Axis:another clue to understanding cardiovascular pathophysiology[J].Int J Mol Sci,2016,17(7):1098.
[7] FANDRIKS L.The renin-angiotensin system and the gastrointestinal mucosa[J].Acta physiolo,2011,201(1):157-167.
[8] VERANO-BRAGA T,MARTINS A L V,MOTTA-SANTOS D,et al.ACE2 in the renin-angiotensin system[J].Clin Sci,2020,134(23):3063-3078.
[9] KHAJAH M A,FATEEL M M,ANANTHALAKSHMI K V,et al.Anti-inflammatory action of angiotensin 1-7 in experimental colitis[J].PLoS One,2016,11(3):e0150861.
[10] SHI Y,LIU T,HE L,et al.Activation of the renin-angiotensin system promotes colitis development[J].Sci Rep,2016,6:27552.
[11] HE L,DU J,CHEN Y,et al.Renin-angiotensin system promotes colonic inflammation by inducing T(H)17 activation via JAK2/STAT pathway[J].Gastrointest Liver Physiol,2019,316(6):G774-G784.
[12] KOSTAKOGLU U,TOPCU A,ATAK M,et al.The protective effects of angiotensin-converting enzyme inhibitor against cecal ligation and puncture-induced sepsis via oxidative stress and inflammation[J].Life Sci,2020,241:117051.
[13] LIU T J,SHI Y Y,WANG E B,et al.AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease[J].Mol Med Rep,2016,13(2):1156-1162.
[14] YISIREYILI M,UCHIDA Y,YAMAMOTO K,et al.Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via at1a signaling and ace2-dependent mechanism in mice[J].Brain Behav Immun,2018,69:167-179.
[15] NOWAK J K,LINDSTROM J C,KALLA R,et al.Age,inflammation,and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor and in inflammatory bowel disease[J].Gastroenterology,2020,159(3):1151-1154,e2.
[16] PATANKAR J V,CHIRIAC M T,LEHMANN M,et al.Severe acute respiratory syndrome coronavirus 2 attachment receptor angiotensin-converting enzyme 2 is decreased in Crohn's disease and regulated by microbial and inflammatory signaling[J].Gastroenterology,2021,160(3):925-928,e4.
[17] DABRITZ J,GERNER P,ENNINGER A,et al.Inflammatory bowel disease in childhood and adolescence[J].Dtsch Arztebl Int,2017,114(19):331-338.
[18] FAIRBRASS K M,HOSHEN D,GRACIE D J,et al.Effect of ACE inhibitors and angiotensinⅡ receptor blockers on disease outcomes in inflammatory bowel disease[J].Gut,2021,70(1):218-219.
[19] SALMENKARI H,KORPELA R,VAPAATALO H.Renin-angiotensin system in intestinal inflammation-angiotensin inhibitors to treat inflammatory bowel diseases[J].Basic Clin Pharmacol Toxicol,2021,129(3):161-172.
[20] MANTAKA A,TSOUKALI E,FRAGKAKI M,et al.Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome?[J].Eur J Gastroenterol Hepatol,2021,33(3):364-371. |